Skip to main content

Want a detailed portfolio tracker?

HYPR
NASDAQ
$0.98

Hyperfine Inc - Class A (HYPR)

Hyperfine Inc. is a pioneering force in medical technology, renowned for developing the world’s first FDA-cleared portable MRI system, which significantly enhances diagnostic imaging accessibility at the point of care. By combining innovation with cost-efficiency, the company improves patient outcomes and facilitates rapid clinical decision-making. As healthcare continues to evolve, Hyperfine is strategically positioned to capture growth opportunities within the expanding imaging diagnostics market, presenting a compelling investment prospect for institutional investors focused on transformative healthcare solutions.
Website: https://www.hyperfinemri.com
68 analysts
Buy
Target: $2.17 (+121.46%)

Market Cap

$100M

Free Cash Flow Yield

-28.76%

Beta (5Y)

1.70

Price Chart

Valuation
Market Cap$100M
P/S6.45
P/B3.00
Profitability
Total Revenue (TTM)$15M
Gross Profit (TTM)$7.85M
EBITDA-$34M
Profit Margin-226.9%
Operating Margin-219.3%
EPS-$0.47
Financial Health
Debt-to-Equity38.2%
Free Cash Flow Yield-28.76%
Growth & Risk
Beta (5Y)1.70
Sharpe Ratio0.37